Rothschild Asset Management Inc. cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,757 shares of the company’s stock after selling 12 shares during the period. Rothschild Asset Management Inc.’s holdings in Henry Schein were worth $505,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Girard Partners LTD. increased its stake in shares of Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock valued at $529,000 after buying an additional 10 shares in the last quarter. Cleararc Capital Inc. increased its stake in shares of Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after buying an additional 11 shares in the last quarter. Penserra Capital Management LLC increased its stake in shares of Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock valued at $258,000 after buying an additional 15 shares in the last quarter. Wetherby Asset Management Inc. increased its stake in shares of Henry Schein by 0.7% in the first quarter. Wetherby Asset Management Inc. now owns 3,147 shares of the company’s stock valued at $535,000 after buying an additional 21 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. increased its stake in shares of Henry Schein by 2.0% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 2,147 shares of the company’s stock valued at $341,000 after buying an additional 43 shares in the last quarter. Institutional investors own 90.87% of the company’s stock.

Henry Schein, Inc. (HSIC) opened at 170.58 on Friday. Henry Schein, Inc. has a 1-year low of $146.23 and a 1-year high of $186.99. The stock has a 50 day moving average of $181.54 and a 200 day moving average of $175.12. The stock has a market cap of $13.49 billion, a P/E ratio of 24.93 and a beta of 1.09.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.64 EPS. Equities analysts anticipate that Henry Schein, Inc. will post $7.28 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/13/rothschild-asset-management-inc-has-505000-position-in-henry-schein-inc-hsic.html.

Several brokerages have recently commented on HSIC. Jefferies Group LLC reiterated a “hold” rating and issued a $177.00 target price on shares of Henry Schein in a report on Friday, July 21st. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 price objective for the company in a report on Tuesday, April 25th. Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. Barrington Research raised their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a report on Wednesday, May 10th. Finally, Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective for the company in a report on Monday, August 7th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. Henry Schein has a consensus rating of “Hold” and a consensus target price of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.